Bishnu Subedi in Carlisle, Pennsylvania

Home Pennsylvania Carlisle

Bishnu Subedi has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 360 Alexander Spring Rd in Carlisle, Pennsylvania.

They're a part of the: Pinnacle Health Cardiovascular Institute Inc medical group which has around 113 members. You can call their office at 717-243-6557 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Bishnu H Subedi Office Phone and Directions

Bishnu Subedi
Pinnacle Health Cardiovascular Institute Inc
360 Alexander Spring Rd
Carlisle, Pennsylvania 17015
717-243-6557

Patient Ratings
Please rate your experience with Bishnu Subedi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 717-243-6557

Enter a starting address:

Healthcare Info for Bishnu Subedi

Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Bishnu Subedi is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 18
PAC (PECOS ID)#: 4183874746
NPI #: 1679866834
NPI Created On: 05/20/2011
NPI Last Updated Listed as: 12/20/2022
Primary Taxonomy Code: 207R00000X
License Number:
MD461147
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Capital Advantage Assurance Company
Highmark Health Insurance Company
Highmark Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Blood test, clotting time
Routine ekg using at least 12 leads including interpretation and report
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Follow-up or limited ultrasound examination of heart
Follow-up or limited ultrasound examination of heart
Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers
Follow-up or limited heart doppler ultrasound study of heart blood flow, valves, and chambers

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $73

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763402160

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: DIABETES

Name of Drug #1: JARDIANCE

Open Associated Drug #1: 0597-0152-30